Don

Antibiotics Don't Prevent Future Urinary Tract Infections, May Cause Resistance in Future Infections

PHILADELPHIA, July 10, 2007 /PRNewswire-USNewswire/ -- After afirst childhood urinary tract infection (UTI), daily antibioticsmay not prevent another such infection, and may actually increasethe risk that the next urinary tract infection is caused byresistant bacteria, according to a new study in the July 11 issueof the Journal of the American Medical Association. In the first larg...

World First Medical Treatment Announced by Researchers at Queen Mary University London and University of Leicester

Breakthrough in Research and Treatment of Rare but DevastatingCondition LONDON, June 1, 2007-Researchers at Queen Mary University Londonand the University of Leicester and have today (Friday June 1)announced a potential breakthrough in the treatment of a rare butdevastating medical condition that can affect children and youngpeople. In a world first, the clinicians and scien...

Generex Biotechnology Vaccine Strategy Presented at International Conference in London

WORCESTER, MA - May 24, 2007 - Generex Biotechnology Corporation(NasdaqCM:GNBT) announced today that Dr. Douglas Powell, Directorof Immunobiology at its wholly-owned Antigen Express subsidiary,has presented Antigen's vaccine development strategy at aninternational conference in London, UK. The international meeting,"Developing New Anti-Infective Agents - Challenges andOpportunities" (<a...

Blood Levels of Paliperidone Extended-Release Tablets are Not Increased by Common Antidepressant

Study shows paroxetine produced no significant drug interactionwith paliperidone ER SAN DIEGO, May 22, 2007 /PRNewswire/ -- After administration ofpaliperidone extended-release (ER) tablets, blood levels of thedrug were not affected when given with a common antidepressant,according to new data presented today at the 160th Annual Meetingof the American Psychiatric Association. Paroxetine,...

Antipsychotic Iloperidone Results Show Favorable Akathisia Profile

SAN DIEGO, May 22, 2007 /PRNewswire-FirstCall/ -- According tostudy results presented today at the 2007 American PsychiatricAssociation annual meeting, iloperidone, an investigationalatypical antipsychotic, was shown to have a favorable akathisiaprofile. Akathisia -- a debilitating sensation of restlessness thatmanifests as an inability to sit still -- is a frequent side effectof antipsy...

Vanda Pharmaceuticals to Present Data on Iloperidone at the 2007 American Psychiatric Association Annual Meeting

ROCKVILLE, Md., May 18, 2007 /PRNewswire-FirstCall/ -- VandaPharmaceuticals Inc. announced today that it will present fourposters on iloperidone at the 160th American PsychiatricAssociation (APA) annual meeting which will be held at the SanDiego Convention Center in San Diego, CA, from May 19 through May24, 2007. The following posters will be presented on May 22, 2007, 12:00to 2:0...

Cellerant Therapeutics Reversed Autoimmune Disease in Lupus Mice with Transplant of Purified Donor Blood Stem Cells

SAN CARLOS, Calif.--(BUSINESS WIRE)--Apr 23, 2007 - CellerantTherapeutics today announced the publication of data suggestingthat established autoimmune disease can be reversed or stabilizedby the transplantation of purified allogeneic (donated)hematopoietic (blood forming) stem cells (HSC) in a mouse study ofSystemic Lupus Erythematosus (SLE). Subjects that underwent thisprocedure exhibited...

Dong-A PharmTech Co., Ltd. Announces Positive Results for Udenafil, Its New Long Acting Drug For Erectile Dysfunction

All Endpoints Met - Up to 88% Efficacy SEOUL, Korea, March 28, 2007 /PRNewswire/ -- Dong-A PharmTechCo., Ltd. announced today that it has completed a 340 patient phase2b "at-home" clinical study for udenafil, its new long acting (12hour half-life) oral phosphodiesterase type 5 (PDE5) inhibitor forerectile dysfunction (ED). The multi-center study conducted in theU.S. was a randomized, doub...